You are here


ART adherence higher among youth in Africa than North America

21 May, 2014

Adolescents and young people (AYA) aged 12 – 24 in Africa and Asia are more likely to be adherent to antiretroviral therapy (ART) than their counterparts in North America and Europe, according to research published in AIDS this week.


New US guidelines for PrEP target groups

16 May, 2014

Truvada was licensed in the US as an HIV prevention measure for at-risk HIV-negative people in July 2012, however, this approval of PrEP by the Food and Drug Adminstration (FDA) was not accompanied by clear guidelines on priority groups to be prescribed the drug. New PrEP guidelines have now been released to clarify key target groups.


HIV criminalisation bill passed in Uganda

13 May, 2014

Ugandan HIV activists are angered with news that an HIV criminalisation bill has been passed by parliament this week. If signed into law by the president, the bill will criminalise deliberate transmission of HIV, in a move that is seen as a significant step away from a rights-based approach to combatting the HIV epidemic.


Research shows male circumcision scale-up successful

7 May, 2014

Large-scale voluntary male medical circumcision (VMMC) programmes can be successfully implemented and impact positively upon new HIV infections in low-resource settings, according to a new series of research published in the PLOS Collection yesterday. The research focuses on the overall success of large-scale VCCM interventions in southern and eastern African countries, and the lessons learnt for going forward.


AVERT-funded home-based care study featured in PLOS ONE

29 April, 2014

Key findings from the Care in the Home Study (CHoS), which was co-funded by AVERT from 2010-2013, have been by published by the journal PLOS ONE this week.


Third-line ART can improve clinical & economic outcomes in SSA

24 April, 2014

A new study has revealed that access to third-line antiretroviral treatment (ART) for HIV can be cost effective in low-resource settings, as long as there are systems in place to identify those who urgently need third-line therapy, and those who could still benefit from second-line therapy.


Rwanda making considerable gains in HIV response

16 April, 2014

Rwanda was one of the first countries globally to achieve universal coverage of HIV treatment. While treatment coverage challenges remain, Rwanda may hold many lessons for other nations in Africa and around the around.


Socioeconomic status associated with HIV mortality in Uganda

10 April, 2014

Unemployment, a lack of formal education and claiming housing benefit are all indicators linked with HIV and AIDS-related mortality in Uganda. The findings, published ahead of print in JAIDS, are among the first to link vital socioeconomic status (SES) indicators, including wealth index components, with HIV and AIDS mortality in low- and middle-income countries.